Adma Biologics (ADMA) Change in Inventory (2011 - 2025)

Adma Biologics' Change in Inventory history runs 13 years deep, the most recent figure standing at $9.8 million for Q4 2025.

• Quarterly Change in Inventory rose 725.67% year-over-year to $9.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $36.2 million (up 1456.42% YoY) and the FY2025 annual result came in at $36.2 million, up 1456.42% from the prior year.
• Change in Inventory was $9.8 million for Q4 2025 at Adma Biologics, up from $5.2 million in the prior quarter.
• Across five years, Change in Inventory topped out at $19.3 million in Q2 2025 and bottomed at -$8.0 million in Q3 2024.
• A 5-year average of $6.2 million and a median of $5.4 million in 2021 frame the typical range for Change in Inventory.
• Annual changes were most pronounced in 2023 — Change in Inventory soared 2571.53% — and 2024, when it slumped 699.48%.
• Adma Biologics' Change in Inventory stood at $10.6 million in 2021, then sank by 96.54% to $366457.0 in 2022, then surged by 2571.53% to $9.8 million in 2023, then slumped by 116.0% to -$1.6 million in 2024, then jumped by 725.67% to $9.8 million in 2025.
• Business Quant data shows ADMA's Change in Inventory at $9.8 million in Q4 2025, $5.2 million in Q3 2025, and $19.3 million in Q2 2025.